Pharmatech AS

Org. no. 984374135 · Fredrikstad · Founded 2002 · 163 employees

Score · fiscal year 2023

33of 100

How to read this: the company is ahead of 23 % of companies in the Morning class Medium in the same sector in 2023. What does this mean?

Rank in the Morning class Medium: 802 of 1,044 · What are Morning company classes?
Place in the whole sector: 2,149 of 2,850 · Industri

Profile

Beaver · Builder

Lower profitability, lower solidity

Position against comparable companies in 2023, not a verdict on the company. Based on profitability 48 and solidity 14 out of 100 among companies in the Morning class Medium in the same sector in 2023. Methodology

Against the sector

Pharmatech AS is 17 points below the median for companies in the Morning class Medium in the same sector in 2023.

Median score 50 among 1,044 companies.

Against companies in the Morning class Medium in the same sector in 2023: operating margin 3.2% (median 5.2%) and equity ratio 17.5% (median 37.3%).

Source: Register of Company Accounts and Central Coordinating RegisterFetched 31 October 2026Report an issue
Key figures · 2023

The numbers behind the score

The numbers behind the score · 2023
MeasureCompanyMedianAhead of
Operating revenue404 MNOK129 MNOK
Operating margin 3.2% 5.2% 35 %
Profit margin 1.9% 4.8% shown, not part of the index
Return on assets 14.0% 11.2% 61 %
Equity ratio 17.5% 37.3% 14 %
Debt-to-equity 4.70 1.66 13 %
Current ratio 1.54 1.52 51 %
Revenue growth – 12.2% not compared
Revenue per employee2.48 MNOK2.53 MNOK

The median and “ahead of” refer to companies in the Morning class Medium in the same sector in 2023. The bar shows the share of companies the figure is ahead of.

With an index of 33, Pharmatech AS does better than 23% of companies in the Morning class Medium in the same sector (1,044 companies) in 2023.

Over time

Score 2023–2025

CompanyMedian0255075100202320242025
  • Pharmatech AS
  • Median: companies in the Morning class Medium in the same sector
Analysis · 2023

What the numbers say

Pharmatech AS had an operating margin of 3.2% and an equity ratio of 17.5% in 2023, and ranks 2,149 of 2,850 in Industri.

This text is generated automatically from the 2023 accounts.

Estimated value · 2023

Three simple methods

The methods give between 21 MNOK and 81 MNOK.

MethodInputMultipleEstimate
P/E Net profit: 6.3 MNOK 10.0 63 MNOK
EV/EBIT Operating profit: 12.9 MNOK
minus net debt 21.9 MNOK
8.0 81 MNOK
P/B Equity: 21.4 MNOK 1.0 21 MNOK

A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation

Indications · 2023

Worth a closer look

No rules were triggered for this year.

Indications based on the latest annual accounts from open data. Not investment or financial advice.

Financial costs were 9.2% of the debt in 2023. The policy rate averaged 3.54 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.

See interest rates, prices and exchange rates for the sector

Data quality

No anomalies found in the figures.

Stress test · 2022

Scenario analysis: the sector's weakest year

We have no accounts for 2022, the sector's weakest year, for this company.

The sector's weakest year was 2022, with a median operating margin of 0.0%. Based on the 10 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology

Components · 2023

What the score is made of

Profitability48 weight 30%
Solidity14 weight 25%
Liquidity51 weight 15%
Growth– no data, left out
Consistency18 weight 15%

Index version 2. Data completeness 85%: the share of the weights that had data.

2023

Questions and answers

How profitable is Pharmatech AS?

The operating margin was 3.2% in 2023, against a median of 5.2% among companies in the Morning class Medium in the same sector. Return on assets was 14.0%.

How solid is Pharmatech AS?

The equity ratio was 17.5% in 2023 (median 37.3%). Debt-to-equity was 4.70 (median 1.66).

What is the liquidity of Pharmatech AS like?

The current ratio was 1.54 in 2023 (median 1.52).

How does Pharmatech AS compare in Industri?

Pharmatech AS ranks 2,149 of 2,850 in Industri for 2023. Among companies in the Morning class Medium it is number 802 of 1,044.

From the Central Coordinating Register

Org. no.
984374135
Legal form
AS
Sector
Industri (10.860)
Morning company class
Medium
Employees
163 registered 10 October 2026
Founded
1 March 2002 24 years in operation
Share capital
0.50 MNOK
Business address
Vallehellene 4, 1664 ROLVSØY (FREDRIKSTAD)
Municipality
Fredrikstad rank 11 of 11 in KOSTRA group 12
Latest accounts filed
2025
LEI
5967007LIEEXZX9M9K51 not renewed (lapsed)

Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre

Ownership and roles

Loading roles …

Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.

Owners and shareholdings will appear here once the shareholder data extract is in place.

Coming · not built yet

Error in the data?

Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.

Report an issue

Figures last fetched 31 October 2026.

Details

Year by year · 2023–2025

Key figure202320242025Trend
Index334765
Rank2,1491,693624
Operating margin3.2%5.4%6.5%
Return on assets14.0%21.1%26.4%
Equity ratio17.5%25.7%33.2%
Current ratio1.541.281.60
Revenue growth–5.1%19.0%

Accounts

From the Brønnøysund Register Centre, in the company's reporting currency (NOK).

Key figure202320242025
Operating revenue404.2 MNOK425.0 MNOK505.7 MNOK
Operating profit12.9 MNOK22.9 MNOK33.0 MNOK
Profit before tax7.9 MNOK23.5 MNOK36.3 MNOK
Net profit6.3 MNOK18.3 MNOK28.2 MNOK
Financial expenses9.2 MNOK3.0 MNOK4.2 MNOK
Total assets121.8 MNOK125.5 MNOK153.5 MNOK
Current assets111.5 MNOK110.4 MNOK136.8 MNOK
Equity21.4 MNOK32.2 MNOK51.0 MNOK
Retained earnings7.7 MNOK18.6 MNOK37.4 MNOK
Total liabilities100.4 MNOK93.3 MNOK102.5 MNOK
Current liabilities72.3 MNOK86.6 MNOK85.4 MNOK

Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 5004305.

Similar companies